UroGen Pharma Reports Third Quarter 2023 Financial Results

Go back to UroGen Pharma Reports Third Quarter 2023 Financial Results
(NASDAQ: URGN) Delayed: 46.44 -3.85 (7.66%)
Previous Close $50.29    52 Week High
Open $49.71    52 Week Low
Day High $49.71    P/E N/A 
Day Low $46.20    EPS
Volume 698,392